This is why we recommend focusing on whole foods while taking Wegovy
View image online ( Eye with uveitis Patients taking glucagon-like peptide-1 (GLP-1) receptor agonists, commonly used to treat Type 2 diabetes and obesity, have a significantly lower risk of developing noninfectious uveitis compared with patients not taking the medication
The medication's absorption and effectiveness are not influenced by food intake, as it is administered subcutaneously and bypasses the digestive system
If difficulties emerged shortly after starting Wegovy or increasing the dose, this may suggest a relationship with the medication's side effects (such as nausea or fatigue) rather than a direct pharmacological effect
Pinpoint growth opportunities Direct investment toward the moments and consumer segments with the greatest potential to grow your brand
Even if it appears normal, the pen should be thrown away as the pen is no longer safe to use